Can Odyssey Therapeutics, Inc. cover its short-term obligations?

Its current ratio is 8.33 — current assets exceed current liabilities.

Where does Odyssey Therapeutics, Inc.'s balance sheet data come from?

Every line is extracted from Odyssey Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Odyssey Therapeutics, Inc. ODTX Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q1 '25
Cash and cash equivalents	$35.72M-14.3%	$41.69M-24.1%	$54.91M—
Short-term investments	$140.03M+0.3%	$139.67M—	——
Total current assets	$185.1M-2.9%	$190.66M—	——
Property and equipment, net	$6.56M-9.1%	$7.21M—	——
Goodwill	$14.07M-1.8%	$14.33M—	——
Intangible assets, net	$160K-38.9%	$262K—	——
Total assets	$229.07M-15.1%	$269.79M—	——
Accounts payable	$8.22M+4.4%	$7.87M—	——
Total current liabilities	$22.21M-16.1%	$26.48M—	——
Total liabilities	$49.21M-9.7%	$54.51M—	——
Common stock	$0—	$0—	——
Retained earnings	-$606.4M-6.7%	-$568.14M—	——
Total stockholders' equity	-$523.69M-7.3%	-$488.28M-17.0%	-$417.17M-9.1%
Total liabilities and stockholders' equity	$229.07M-15.1%	$269.79M—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can Odyssey Therapeutics, Inc. cover its short-term obligations?: Its current ratio is 8.33 — current assets exceed current liabilities.
Where does Odyssey Therapeutics, Inc.'s balance sheet data come from?: Every line is extracted from Odyssey Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.